BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 15113923)

  • 21. Peptide ligands selected with CD4-induced epitopes on native dualtropic HIV-1 envelope proteins mimic extracellular coreceptor domains and bind to HIV-1 gp120 independently of coreceptor usage.
    Dervillez X; Klaukien V; Dürr R; Koch J; Kreutz A; Haarmann T; Stoll M; Lee D; Carlomagno T; Schnierle B; Möbius K; Königs C; Griesinger C; Dietrich U
    J Virol; 2010 Oct; 84(19):10131-8. PubMed ID: 20660187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1.
    Bouma P; Leavitt M; Zhang PF; Sidorov IA; Dimitrov DS; Quinnan GV
    J Virol; 2003 Jul; 77(14):8061-71. PubMed ID: 12829845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation of the CD4 and CXCR4 binding properties of human immunodeficiency virus type 1 gp120 by deletion of the first putative alpha-helical conserved structure.
    Missé D; Cerutti M; Schmidt I; Jansen A; Devauchelle G; Jansen F; Veas F
    J Virol; 1998 Sep; 72(9):7280-8. PubMed ID: 9696823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of CD4 and coreceptors in binding, endocytosis, and proteolysis of gp120 envelope glycoproteins derived from human immunodeficiency virus type 1.
    Kozak SL; Kuhmann SE; Platt EJ; Kabat D
    J Biol Chem; 1999 Aug; 274(33):23499-507. PubMed ID: 10438529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
    Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
    J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL; Drummer HE; Wilson KA; Poumbourios P
    J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.
    LaBranche CC; Hoffman TL; Romano J; Haggarty BS; Edwards TG; Matthews TJ; Doms RW; Hoxie JA
    J Virol; 1999 Dec; 73(12):10310-9. PubMed ID: 10559349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.
    Hoffman TL; LaBranche CC; Zhang W; Canziani G; Robinson J; Chaiken I; Hoxie JA; Doms RW
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6359-64. PubMed ID: 10339592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop.
    Wang H; Cohen AA; Galimidi RP; Gristick HB; Jensen GJ; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7151-E7158. PubMed ID: 27799557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
    Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
    J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strain-Dependent Activation and Inhibition of Human Immunodeficiency Virus Entry by a Specific PF-68742 Stereoisomer.
    Zhao C; Princiotto AM; Nguyen HT; Zou S; Zhao ML; Zhang S; Herschhorn A; Farrell M; Pahil K; Melillo B; Sambasivarao SV; Abrams C; Smith AB; Madani N; Sodroski J
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31391272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
    Laakso MM; Lee FH; Haggarty B; Agrawal C; Nolan KM; Biscone M; Romano J; Jordan AP; Leslie GJ; Meissner EG; Su L; Hoxie JA; Doms RW
    PLoS Pathog; 2007 Aug; 3(8):e117. PubMed ID: 17722977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide mimic of the HIV envelope gp120-gp41 interface.
    Kim S; Pang HB; Kay MS
    J Mol Biol; 2008 Feb; 376(3):786-97. PubMed ID: 18178220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
    Doranz BJ; Baik SS; Doms RW
    J Virol; 1999 Dec; 73(12):10346-58. PubMed ID: 10559353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
    Sattentau QJ; Moore JP
    J Exp Med; 1991 Aug; 174(2):407-15. PubMed ID: 1713252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cells preferentially transfer CXCR4-using human immunodeficiency virus type 1 variants to CD4+ T lymphocytes in trans.
    van Montfort T; Thomas AA; Pollakis G; Paxton WA
    J Virol; 2008 Aug; 82(16):7886-96. PubMed ID: 18524826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein.
    Wyatt R; Desjardin E; Olshevsky U; Nixon C; Binley J; Olshevsky V; Sodroski J
    J Virol; 1997 Dec; 71(12):9722-31. PubMed ID: 9371638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
    Binley JM; Sanders RW; Clas B; Schuelke N; Master A; Guo Y; Kajumo F; Anselma DJ; Maddon PJ; Olson WC; Moore JP
    J Virol; 2000 Jan; 74(2):627-43. PubMed ID: 10623724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.